| | A randomized, double-blind, placebo-controlled, parallel group, phase III multicenter study of intravenous secukinumab to compare efficacy at 16 weeks with placebo and to assess safety and tolerabilit . . . |
Ongoing |
30 Jul 2020 |
| | A Randomized, Double-blind, Placebo-controlled, Phase Ib/II Clinical Study to Evaluate the Preliminary Efficacy, Safety, Pharmacokinetic Profiles and Immunogenecity of JS016 (Recombinant Human Anti-SA . . . |
Ongoing |
28 May 2021 |
| | A Randomized, Double-blinded, Multicenter, Phase III Clinical Study of HLX10 (Recombinant Humanized Anti-PD-1 Monoclonal Antibody Injection) Combined with Chemotherapy versus Placebo with Chemotherapy . . . |
Terminated |
19 Jul 2021 |
| | A Randomized, Multicenter, Double-Blind, Parallel-Group, Placebo-Controlled Study to Investigate the Efficacy and Safety of Canagliflozin in Children and Adolescents (≥10to . . . |
Ongoing |
14 Aug 2020 |
| | A Randomized, Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Acalabrutinib versus Chlorambucil plus Rituximab in Subjects with Previously Untreated Chronic Lymphocytic L . . . |
Pending |
12 May 2020 |
| | A randomized, observer blinded, controlled trial to evaluate the safety and immunogenicity of a new formulation of Euvichol® (killed bivalent (O1 and O139) whole cell oral cholera vaccine (WC-OCV) ma . . . |
Completed |
22 Apr 2019 |
| | A Randomized, Open Label Phase III Study to Evaluate the Efficacy and Safety of Oral Afatinib (BIBW 2992) versus Intravenous Methotrexate in Patients with Recurrent and/or Metastatic Head and Neck Squ . . . |
Completed |
01 Jul 2019 |
| | A Randomized, Placebo-Controlled Phase I/IIa Study to Evaluate the Safety, Tolerability, and Efficacy of PG04 Ointment in Subjects Colonized with Staphylococcus aureus . . . |
Ongoing |
30 Nov -0001 |
| | A Regional, Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Severe Uncontrolled Asthma . . . |
Ongoing |
26 Nov 2020 |
| | A Study of Guselkumab in Participants with Active Psoriatic Arthritis |
Pending |
30 Nov -0001 |
| | A Study of Pembrolizumab (MK-3475) for First Line Treatment of Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck (MK-3475-048/KEYNOTE-048) . . . |
Ongoing |
09 Jul 2021 |
| | A study of the efficacy and safety of bardoxolone methyl in patients with connective tissue disease-associated pulmonary arterial hypertension . . . |
Completed |
13 Nov 2019 |
| | A Study of Vericiguat in Participants With Heart Failure With Reduced Ejection Fraction (HFrEF) (MK-1242-001) (VICTORIA) . . . |
Completed |
13 Apr 2021 |
| | A Study to Assess the Safety, Reactogenicity and Immunogenicity of a Trivalent Inactivated Poliovirus Vaccine (IPV) Based on Sabin Strains Compared to Conventional Salk IPV in a 6, 10 and 14 Weeks of . . . |
Completed |
28 Sep 2020 |
| | A study to determine the safety and immunogenicity of a new vaccine for Polio in healthy infants |
Completed |
05 Mar 2020 |
| | A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients with Chronic Kidney Disease . . . |
Completed |
20 Jan 2021 |
| | A Study to evaluate the efficacy and safety of dapirolizumab pegol in study participants with moderately to severely active systemic lupus erythematosus . . . |
Ongoing |
23 Jun 2021 |
| | A Three-Arm, Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Safety and Efficacy of Once-Daily and Twice-Daily Dosing of a Novel Hydrocortisone Acetate 90 mg Suppository For . . . |
Ongoing |
06 Jul 2020 |
| | A Two-Part, Open-Label, Randomized, Phase II/III Study of Dinutuximab and Irinotecan versus Irinotecan for Second Line Treatment of Subjects with Relapsed or Refractory Small Cell Lung Cancer . . . |
Completed |
10 Jun 2020 |
| | ACTIV-2: Adapt Out COVID |
Ongoing |
30 Nov -0001 |
| | An adaptive seamless randomized, double-blind, placebo controlled, dose ranging study to investigate the efficacy and safety of LNP023 in primary IgA nephropathy patients . . . |
Terminated |
20 May 2021 |
| | An Adaptive, Randomized, Double-blinded, Placebo-controlled Phase II/III Trial of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in High-Risk Outpatients With COVID-19 (MAOP3 Trial) . . . |
Ongoing |
29 Jul 2021 |
| | An Adaptive, Randomized, Double-blinded, Placebo-controlled, Phase II/III Trial of Monoclonal Antibody SCTA01 Against SARS-CoV-2 in Patients With Severe COVID-19 Admitted to High Dependence or Inten . . . |
Pending |
10 Jun 2021 |
| | An exploratory maintenance trial of BI 655064 in patients with lupus nephritis |
Ongoing |
06 May 2021 |
| | An Extended Access Program to Assess Long-Term Safety of Bardoxolone Methyl in Patients with Pulmonary Hypertension . . . |
Terminated |
09 Jun 2021 |